Thrombolysis at 3–4.5 hours after acute ischemic stroke onset–evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry

N Shobha, AM Buchan, MD Hill… - Cerebrovascular …, 2011 - karger.com
Background: Extending the therapeutic window for thrombolysis is an important strategy in
maximizing the proportion of patients treated. ECASS III examined a 3–4.5-hour window and …
被引用次数：136 相关文章

Thrombolysis at 3-4.5 Hours after Acute Ischemic Stroke Onset-Evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) Registry.

N Shobha, AM Buchan, MD Hill - Cerebrovascular Diseases, 2011 - search.ebscohost.com
Background: Extending the therapeutic window for thrombolysis is an important strategy in
maximizing the proportion of patients treated. ECASS III examined a 3-4.5-hour window and …

Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.

N Shobha, A Buchan, MD Hill - Cerebrovascular diseases (Basel …, 2011 - ora.ox.ac.uk
BACKGROUND: Extending the therapeutic window for thrombolysis is an important strategy
in maximizing the proportion of patients treated. ECASS III examined a 3-4.5-hour window …

Thrombolysis at 3–4.5 Hours after Acute Ischemic Stroke Onset–Evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) Registry

N Shobha, AM Buchan, MD Hill - Cerebrovascular Diseases, 2010 - cir.nii.ac.jp
抄録< jats: p> Background: Extending the therapeutic window for thrombolysis is an
important strategy in maximizing the proportion of patients treated. ECASS III examined a 3 …

Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.

N Shobha, AM Buchan, MD Hill - … Diseases (Basel, Switzerland), 2010 - europepmc.org
Background Extending the therapeutic window for thrombolysis is an important strategy in
maximizing the proportion of patients treated. ECASS III examined a 3-4.5-hour window and …

Thrombolysis at 3-4.5 Hours after Acute Ischemic Stroke Onset-Evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) Registry

N Shobha, AM Buchan, MD Hill - Cerebrovascular Diseases, 2011 - search.proquest.com
Background: Extending the therapeutic window for thrombolysis is an important strategy in
maximizing the proportion of patients treated. ECASS III examined a 3-4.5-hour window and …
[PDF] researchgate.net

[PDF][PDF] Thrombolysis at 3–4.5 Hours after Acute Ischemic Stroke Onset–Evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) Registry

N Shobha, AM Buchan - Cerebrovasc Dis, 2011 - researchgate.net
Background: Extending the therapeutic window for thrombolysis is an important strategy in
maximizing the proportion of patients treated. ECASS III examined a 3–4.5-hour window and …

Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry

N Shobha, AM Buchan, MD Hill… - Cerebrovascular …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Extending the therapeutic window for thrombolysis is an important strategy in
maximizing the proportion of patients treated. ECASS III examined a 3-4.5-hour window and …

Thrombolysis at 3–4.5 Hours after Acute Ischemic Stroke Onset–Evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) Registry

N Shobha, AM Buchan, MD Hill… - Cerebrovascular …, 2011 - karger.com
Background: Extending the therapeutic window for thrombolysis is an important strategy in
maximizing the proportion of patients treated. ECASS III examined a 3–4.5-hour window and …